Literature DB >> 6123306

Combined hepatotoxicity and neurotoxicity following sulphasalazine administration.

M D Smith, G E Gibson, R Rowland.   

Abstract

Two cases of hepatotoxicity following sulphasalazine administration are reported. Each patient became ill after her initial exposure to sulphasalazine and after being re-exposed to the drug. In both instances there was an interval of three weeks between receiving the drug for the first time and the onset of the toxic reaction. In the first patient, hepatotoxicity occurred after initial exposure and following the second course of sulphasalazine. Mild neurotoxicity was seen following second exposure to sulphasalazine. In the second patient, hepatotoxicity occurred following the initial exposure to sulphasalazine but after reexposure the only abnormality in liver function tests present was a slight rise in the serum level of gamma glutamyl transpeptidase. In this patient, life-threatening neurotoxicity occurred each time that the patient received sulphasalazine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6123306     DOI: 10.1111/j.1445-5994.1982.tb02433.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  7 in total

1.  A case of possible sulfasalazine neurotoxicity.

Authors:  R Bhalotra; L Loring; J J Massarelli
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

2.  An unusual cause for collapse in a patient with arthritis.

Authors:  K J Heath; M J Sampson; S A Ridley
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

3.  Peripheral neuropathy and mesalazine.

Authors:  D K Woodward
Journal:  BMJ       Date:  1989-11-11

Review 4.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

5.  Sensorimotor neuropathy with sulphasalazine.

Authors:  T R Price
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

Review 6.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

7.  Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis.

Authors:  L G Quallich; J Greenson; H M Haftel; R J Fontana
Journal:  BMC Gastroenterol       Date:  2001-08-29       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.